Literature DB >> 24013167

Posttransplant lymphoproliferative disorder of the central nervous system.

Christian Kempf1, Marianne Tinguely, Elisabeth J Rushing.   

Abstract

Posttransplant lymphoproliferative disorder (PTLD) involves uncommon, severe complications following the transplantation of solid organs, bone marrow and stem cells. Despite comprising mainly lymphoid proliferations that are predominantly driven by lymphotropic Epstein-Barr virus (EBV) infections, PTLD often displays substantial morphologic heterogeneity that can pose diagnostic challenges. With the steady increase in transplantations accompanied by potent immunosuppressive therapy, it is important to heighten awareness of this entity among clinicians and pathologists. In comparison to systemic PTLD, cases that primarily manifest in the central nervous system (CNS) are reported to be more severe and to exhibit unique characteristics. So far, only isolated cases and small series have been reported describing CNS involvement in PTLD. In this article, we review the current knowledge, focusing on the histopathological features of primary CNS lymphoproliferative disorders following organ transplantation.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2013        PMID: 24013167     DOI: 10.1159/000347225

Source DB:  PubMed          Journal:  Pathobiology        ISSN: 1015-2008            Impact factor:   4.342


  7 in total

Review 1.  Management of Non-Diffuse Large B Cell Lymphoma Post-Transplant Lymphoproliferative Disorder.

Authors:  Ajay Major; Manali Kamdar
Journal:  Curr Treat Options Oncol       Date:  2018-05-24

Review 2.  Role of microRNAs in primary central nervous system lymphomas.

Authors:  Xin Yu; Zheng Li; Jianxiong Shen; Matthew T V Chan; William Ka Kei Wu
Journal:  Cell Prolif       Date:  2016-03-16       Impact factor: 6.831

3.  Post-transplant lymphoproliferative disorder of the cauda equina in a kidney transplant recipient.

Authors:  Yuichiro Nishiyama; Akio Iwanami; Shuji Mikami; Soya Kawabata; Osahiko Tsuji; Narihito Nagoshi; Eijiro Okada; Nobuyuki Fujita; Mitsuru Yagi; Ken Ishii; Morio Matsumoto; Masaya Nakamura; Kota Watanabe
Journal:  Spinal Cord Ser Cases       Date:  2018-11-06

4.  Successful treatment of Epstein-Barr virus-related post-transplant lymphoproliferative disease with central nervous system involvement following allogeneic haematopoietic stem cell transplantation - a case study.

Authors:  Małgorzata Wróblewska; Lidia A Gil; Mieczysław A Komarnicki
Journal:  Cent Eur J Immunol       Date:  2015-04-22       Impact factor: 2.085

5.  Epstein-Barr Virus-associated Lymphoproliferative Disorder with Encephalitis Following Anti-thymocyte Globulin for Aplastic Anemia Resolved with Rituximab Therapy: A Case Report and Literature Review.

Authors:  Kiyomi Mashima; Shingo Yano; Hiroki Yokoyama; Takeshi Saito; Tomohito Machishima; Takaki Shimada; Yuichi Yahagi; Shinobu Takahara; Katsuki Sugiyama; Yoji Ogasawara; Jiro Minami; Yutaro Kamiyama; Atsushi Katsube; Kazuhito Suzuki; Sayaka Ohshima; Hisashi Yamada; Noriko Usui; Keisuke Aiba
Journal:  Intern Med       Date:  2017-03-17       Impact factor: 1.271

6.  A Rare Presentation of Isolated CNS Posttransplantation Lymphoproliferative Disorder.

Authors:  Jaime Morris; Casey Smith; Andrew Streicher; Allison Magnuson; Susan Newman; Robert Bertoli
Journal:  Case Rep Oncol Med       Date:  2017-01-02

7.  Clinical characteristics of Epstein-Barr virus infection in the pediatric nervous system.

Authors:  Huan Cheng; Doudou Chen; Xiaoling Peng; Peng Wu; Li Jiang; Yue Hu
Journal:  BMC Infect Dis       Date:  2020-11-25       Impact factor: 3.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.